ISRG vs PCVX
Intuitive Surgical vs Vaxcyte, Inc. — AI-powered side-by-side comparison
ISRG
Intuitive Surgical
60
Buy
VS
PCVX
Vaxcyte, Inc.
64
Buy
| Metric | ISRG | PCVX |
|---|
| AI Score |
60
|
64
|
| Price |
$371.73
|
$61.17
|
| P/E Ratio |
42.21×
|
-8.10×
|
| ROE |
16.0%
|
-28.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
66.7%
|
0.0%
|
| Debt / Equity |
0.00×
|
0.04×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
40.0
|
61.0
|
| Beta |
1.46
|
1.21
|
| Expected Upside |
+18.5%
|
+2.2%
|
AI Committee View
Current Innellis committee reasoning for ISRG versus PCVX.
PCVX leads by 4 points.
PCVX scores 64/100 (Buy) versus ISRG at 60/100 (Buy).
ISRG Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 17.8% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 45.2 is expensive by classic value standards — Value
- Price-to-book of 11.3x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
PCVX Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- ROE of only -37.6% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 21.2% signals elevated volatility — Risk